| Ytd | 11.26% | |
| 1y | 47.80% |
| Open | 5.30 | Prev Close | 5.33 | Low | 4.96 | High | 5.40 | Mkt Cap | 6.40M |
| Vol | 7.15K | Avg Vol | 28.16K | EPS | -8.16 | P/E | N/A | Forward P/E | -0.02 |
| Beta | 0.74 | Short Ratio | 0.05 | Inst. Own | 0.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 5.05 | 200-d Avg | 4.93 | 1yr Est | 2625.00 |
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ENDRA Life Sciences In
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'
ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," âASPIâ or the "Company"), an advanced material
DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP
ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes," "ASPI" or the "Company"), a
Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Ren
Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price tar
Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the anal
The analysis combined data from 64 patients in the U.S. and Canada, including an external validation
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(3.25) per share which missed the an
Costs Associated with Exit or Disposal Activities. On March 25, 2026, ENDRA Life Sciences Inc. (the
AMTD Digital Inc - ADR (NYSE: HKD) jumped 24.4% in pre-market trading after reporting a 565.7% incre
Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-
TAEUS Liver demonstrates strong agreement with the industry's imaging gold standard, MRI‑PDFF, a
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(2.10) per share which missed the an
A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some